PRKCD and neoplasm: Tumor-bearing normal mice, lentivirally silenced with control shRNA or PKCδ shRNA mediated mice were treated with PBS or cisplatin (10 mg/kg bw) for 7 days after day 3 of tumor cell inoculation.